Selected research
Industry Research
Nicotinamide Riboside Malate Industry Research Report 2026
Market perspective
The global Nicotinamide Riboside Malate market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Nicotinamide Riboside Malate is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Nicotinamide Riboside Malate is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Nicotinamide Riboside Malate is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Nicotinamide Riboside Malate include , among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Nicotinamide Riboside Malate market in revenue (US$ million) and, where applicable, sales volume (t), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/t) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Nicotinamide Riboside Malate.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Nicotinamide Riboside Malate Market by Company
Invertin Biotech
Xi'an Prius Biological Engineering Co.,Ltd
Shenzhen Hygieia Biotechnology Co., Ltd
Sihuan Pharmaceutical Holdings Group Ltd.
NANJING NUOYUN BIOTECHNOLOGY CO.,LTD.
Hubei Yanke Times Technology Co., Ltd.
Wuhan Hanxiang Biotechnology Co., Ltd.
Bontac Bio-Engineering (Shenzhen) Co., Ltd.
Xi'an Chen Lang Biological Technology Co., Ltd.
Wuhan Fortuna Chemical Co.,Ltd
Lucerna-Chem AG
Gihi Chemicals
Creative Enzymes
Bicells Science Ltd
Nicotinamide Riboside Malate Segment by Type
Purity: Greater than 99%
Purity: Less than 99%
Nicotinamide Riboside Malate Segment by Application
Nutritional Supplements
Research
Other
Nicotinamide Riboside Malate Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nicotinamide Riboside Malate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nicotinamide Riboside Malate and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nicotinamide Riboside Malate.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Nicotinamide Riboside Malate manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Nicotinamide Riboside Malate by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Nicotinamide Riboside Malate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Purity: Greater than 99%
- Purity: Less than 99%
Applications
- Nutritional Supplements
- Research
- Other
Companies covered
- Invertin Biotech
- Xi'an Prius Biological Engineering Co.,Ltd
- Shenzhen Hygieia Biotechnology Co., Ltd
- Sihuan Pharmaceutical Holdings Group Ltd.
- NANJING NUOYUN BIOTECHNOLOGY CO.,LTD.
- Hubei Yanke Times Technology Co., Ltd.
- Wuhan Hanxiang Biotechnology Co., Ltd.
- Bontac Bio-Engineering (Shenzhen) Co., Ltd.
- Xi'an Chen Lang Biological Technology Co., Ltd.
- Wuhan Fortuna Chemical Co.,Ltd
- Lucerna-Chem AG
- Gihi Chemicals
- Creative Enzymes
- Bicells Science Ltd
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Nicotinamide Riboside Malate by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Purity: Greater than 99%
- 2.2.3 Purity: Less than 99%
- 2.3 Nicotinamide Riboside Malate by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Nutritional Supplements
- 2.3.3 Research
- 2.3.4 Other
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Nicotinamide Riboside Malate Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Nicotinamide Riboside Malate Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Nicotinamide Riboside Malate Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Nicotinamide Riboside Malate Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Nicotinamide Riboside Malate Production by Manufacturers (2021-2026)
- 3.2 Global Nicotinamide Riboside Malate Production Value by Manufacturers (2021-2026)
- 3.3 Global Nicotinamide Riboside Malate Average Price by Manufacturers (2021-2026)
- 3.4 Global Nicotinamide Riboside Malate Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Nicotinamide Riboside Malate Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Nicotinamide Riboside Malate Manufacturers, Product Type & Application
- 3.7 Global Nicotinamide Riboside Malate Manufacturers Established Date
- 3.8 Global Nicotinamide Riboside Malate Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Invertin Biotech
- 4.1.1 Invertin Biotech Nicotinamide Riboside Malate Company Information
- 4.1.2 Invertin Biotech Nicotinamide Riboside Malate Business Overview
- 4.1.3 Invertin Biotech Nicotinamide Riboside Malate Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 Invertin Biotech Product Portfolio
- 4.1.5 Invertin Biotech Recent Developments
- 4.2 Xi'an Prius Biological Engineering Co.,Ltd
- 4.2.1 Xi'an Prius Biological Engineering Co.,Ltd Nicotinamide Riboside Malate Company Information
- 4.2.2 Xi'an Prius Biological Engineering Co.,Ltd Nicotinamide Riboside Malate Business Overview
- 4.2.3 Xi'an Prius Biological Engineering Co.,Ltd Nicotinamide Riboside Malate Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 Xi'an Prius Biological Engineering Co.,Ltd Product Portfolio
- 4.2.5 Xi'an Prius Biological Engineering Co.,Ltd Recent Developments
- 4.3 Shenzhen Hygieia Biotechnology Co., Ltd
- 4.3.1 Shenzhen Hygieia Biotechnology Co., Ltd Nicotinamide Riboside Malate Company Information
- 4.3.2 Shenzhen Hygieia Biotechnology Co., Ltd Nicotinamide Riboside Malate Business Overview
- 4.3.3 Shenzhen Hygieia Biotechnology Co., Ltd Nicotinamide Riboside Malate Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 Shenzhen Hygieia Biotechnology Co., Ltd Product Portfolio
- 4.3.5 Shenzhen Hygieia Biotechnology Co., Ltd Recent Developments
- 4.4 Sihuan Pharmaceutical Holdings Group Ltd.
- 4.4.1 Sihuan Pharmaceutical Holdings Group Ltd. Nicotinamide Riboside Malate Company Information
- 4.4.2 Sihuan Pharmaceutical Holdings Group Ltd. Nicotinamide Riboside Malate Business Overview
- 4.4.3 Sihuan Pharmaceutical Holdings Group Ltd. Nicotinamide Riboside Malate Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 Sihuan Pharmaceutical Holdings Group Ltd. Product Portfolio
- 4.4.5 Sihuan Pharmaceutical Holdings Group Ltd. Recent Developments
- 4.5 NANJING NUOYUN BIOTECHNOLOGY CO.,LTD.
- 4.5.1 NANJING NUOYUN BIOTECHNOLOGY CO.,LTD. Nicotinamide Riboside Malate Company Information
- 4.5.2 NANJING NUOYUN BIOTECHNOLOGY CO.,LTD. Nicotinamide Riboside Malate Business Overview
- 4.5.3 NANJING NUOYUN BIOTECHNOLOGY CO.,LTD. Nicotinamide Riboside Malate Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 NANJING NUOYUN BIOTECHNOLOGY CO.,LTD. Product Portfolio
- 4.5.5 NANJING NUOYUN BIOTECHNOLOGY CO.,LTD. Recent Developments
- 4.6 Hubei Yanke Times Technology Co., Ltd.
- 4.6.1 Hubei Yanke Times Technology Co., Ltd. Nicotinamide Riboside Malate Company Information
- 4.6.2 Hubei Yanke Times Technology Co., Ltd. Nicotinamide Riboside Malate Business Overview
- 4.6.3 Hubei Yanke Times Technology Co., Ltd. Nicotinamide Riboside Malate Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 Hubei Yanke Times Technology Co., Ltd. Product Portfolio
- 4.6.5 Hubei Yanke Times Technology Co., Ltd. Recent Developments
- 4.7 Wuhan Hanxiang Biotechnology Co., Ltd.
- 4.7.1 Wuhan Hanxiang Biotechnology Co., Ltd. Nicotinamide Riboside Malate Company Information
- 4.7.2 Wuhan Hanxiang Biotechnology Co., Ltd. Nicotinamide Riboside Malate Business Overview
- 4.7.3 Wuhan Hanxiang Biotechnology Co., Ltd. Nicotinamide Riboside Malate Production Capacity, Value and Gross Margin (2021-2026)
- 4.7.4 Wuhan Hanxiang Biotechnology Co., Ltd. Product Portfolio
- 4.7.5 Wuhan Hanxiang Biotechnology Co., Ltd. Recent Developments
- 4.8 Bontac Bio-Engineering (Shenzhen) Co., Ltd.
- 4.8.1 Bontac Bio-Engineering (Shenzhen) Co., Ltd. Nicotinamide Riboside Malate Company Information
- 4.8.2 Bontac Bio-Engineering (Shenzhen) Co., Ltd. Nicotinamide Riboside Malate Business Overview
- 4.8.3 Bontac Bio-Engineering (Shenzhen) Co., Ltd. Nicotinamide Riboside Malate Production Capacity, Value and Gross Margin (2021-2026)
- 4.8.4 Bontac Bio-Engineering (Shenzhen) Co., Ltd. Product Portfolio
- 4.8.5 Bontac Bio-Engineering (Shenzhen) Co., Ltd. Recent Developments
- 4.9 Xi'an Chen Lang Biological Technology Co., Ltd.
- 4.9.1 Xi'an Chen Lang Biological Technology Co., Ltd. Nicotinamide Riboside Malate Company Information
- 4.9.2 Xi'an Chen Lang Biological Technology Co., Ltd. Nicotinamide Riboside Malate Business Overview
- 4.9.3 Xi'an Chen Lang Biological Technology Co., Ltd. Nicotinamide Riboside Malate Production Capacity, Value and Gross Margin (2021-2026)
- 4.9.4 Xi'an Chen Lang Biological Technology Co., Ltd. Product Portfolio
- 4.9.5 Xi'an Chen Lang Biological Technology Co., Ltd. Recent Developments
- 4.10 Wuhan Fortuna Chemical Co.,Ltd
- 4.10.1 Wuhan Fortuna Chemical Co.,Ltd Nicotinamide Riboside Malate Company Information
- 4.10.2 Wuhan Fortuna Chemical Co.,Ltd Nicotinamide Riboside Malate Business Overview
- 4.10.3 Wuhan Fortuna Chemical Co.,Ltd Nicotinamide Riboside Malate Production Capacity, Value and Gross Margin (2021-2026)
- 4.10.4 Wuhan Fortuna Chemical Co.,Ltd Product Portfolio
- 4.10.5 Wuhan Fortuna Chemical Co.,Ltd Recent Developments
- 4.11 Lucerna-Chem AG
- 4.11.1 Lucerna-Chem AG Nicotinamide Riboside Malate Company Information
- 4.11.2 Lucerna-Chem AG Nicotinamide Riboside Malate Business Overview
- 4.11.3 Lucerna-Chem AG Nicotinamide Riboside Malate Production Capacity, Value and Gross Margin (2021-2026)
- 4.11.4 Lucerna-Chem AG Product Portfolio
- 4.11.5 Lucerna-Chem AG Recent Developments
- 4.12 Gihi Chemicals
- 4.12.1 Gihi Chemicals Nicotinamide Riboside Malate Company Information
- 4.12.2 Gihi Chemicals Nicotinamide Riboside Malate Business Overview
- 4.12.3 Gihi Chemicals Nicotinamide Riboside Malate Production Capacity, Value and Gross Margin (2021-2026)
- 4.12.4 Gihi Chemicals Product Portfolio
- 4.12.5 Gihi Chemicals Recent Developments
- 4.13 Creative Enzymes
- 4.13.1 Creative Enzymes Nicotinamide Riboside Malate Company Information
- 4.13.2 Creative Enzymes Nicotinamide Riboside Malate Business Overview
- 4.13.3 Creative Enzymes Nicotinamide Riboside Malate Production Capacity, Value and Gross Margin (2021-2026)
- 4.13.4 Creative Enzymes Product Portfolio
- 4.13.5 Creative Enzymes Recent Developments
- 4.14 Bicells Science Ltd
- 4.14.1 Bicells Science Ltd Nicotinamide Riboside Malate Company Information
- 4.14.2 Bicells Science Ltd Nicotinamide Riboside Malate Business Overview
- 4.14.3 Bicells Science Ltd Nicotinamide Riboside Malate Production Capacity, Value and Gross Margin (2021-2026)
- 4.14.4 Bicells Science Ltd Product Portfolio
- 4.14.5 Bicells Science Ltd Recent Developments
5 Global Nicotinamide Riboside Malate Production by Region
- 5.1 Global Nicotinamide Riboside Malate Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Nicotinamide Riboside Malate Production by Region: 2021-2032
- 5.2.1 Global Nicotinamide Riboside Malate Production by Region: 2021-2026
- 5.2.2 Global Nicotinamide Riboside Malate Production Forecast by Region (2027-2032)
- 5.3 Global Nicotinamide Riboside Malate Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Nicotinamide Riboside Malate Production Value by Region: 2021-2032
- 5.4.1 Global Nicotinamide Riboside Malate Production Value by Region: 2021-2026
- 5.4.2 Global Nicotinamide Riboside Malate Production Value Forecast by Region (2027-2032)
- 5.5 Global Nicotinamide Riboside Malate Market Price Analysis by Region (2021-2026)
- 5.6 Global Nicotinamide Riboside Malate Production and Value, YOY Growth
- 5.6.1 North America Nicotinamide Riboside Malate Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Nicotinamide Riboside Malate Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Nicotinamide Riboside Malate Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Nicotinamide Riboside Malate Production Value Estimates and Forecasts (2021-2032)
6 Global Nicotinamide Riboside Malate Consumption by Region
- 6.1 Global Nicotinamide Riboside Malate Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Nicotinamide Riboside Malate Consumption by Region (2021-2032)
- 6.2.1 Global Nicotinamide Riboside Malate Consumption by Region: 2021-2026
- 6.2.2 Global Nicotinamide Riboside Malate Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Nicotinamide Riboside Malate Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Nicotinamide Riboside Malate Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Nicotinamide Riboside Malate Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Nicotinamide Riboside Malate Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Nicotinamide Riboside Malate Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Nicotinamide Riboside Malate Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Nicotinamide Riboside Malate Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Nicotinamide Riboside Malate Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Nicotinamide Riboside Malate Production by Type (2021-2032)
- 7.1.1 Global Nicotinamide Riboside Malate Production by Type (2021-2032) & (t)
- 7.1.2 Global Nicotinamide Riboside Malate Production Market Share by Type (2021-2032)
- 7.2 Global Nicotinamide Riboside Malate Production Value by Type (2021-2032)
- 7.2.1 Global Nicotinamide Riboside Malate Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Nicotinamide Riboside Malate Production Value Market Share by Type (2021-2032)
- 7.3 Global Nicotinamide Riboside Malate Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Nicotinamide Riboside Malate Production by Application (2021-2032)
- 8.1.1 Global Nicotinamide Riboside Malate Production by Application (2021-2032) & (t)
- 8.1.2 Global Nicotinamide Riboside Malate Production Market Share by Application (2021-2032)
- 8.2 Global Nicotinamide Riboside Malate Production Value by Application (2021-2032)
- 8.2.1 Global Nicotinamide Riboside Malate Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Nicotinamide Riboside Malate Production Value Market Share by Application (2021-2032)
- 8.3 Global Nicotinamide Riboside Malate Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Nicotinamide Riboside Malate Value Chain Analysis
- 9.1.1 Nicotinamide Riboside Malate Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Nicotinamide Riboside Malate Production Mode & Process
- 9.2 Nicotinamide Riboside Malate Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Nicotinamide Riboside Malate Distributors
- 9.2.3 Nicotinamide Riboside Malate Customers
10 Global Nicotinamide Riboside Malate Analyzing Market Dynamics
- 10.1 Nicotinamide Riboside Malate Industry Trends
- 10.2 Nicotinamide Riboside Malate Industry Drivers
- 10.3 Nicotinamide Riboside Malate Industry Opportunities and Challenges
- 10.4 Nicotinamide Riboside Malate Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst